Intracranial Injection of NK-92/5.28.z Cells in Combination With Intravenous Ezabenlimab in Patients With Recurrent HER2-positive Glioblastoma
Clinical trial NCT03383978 · RECRUITING
Trial details
- NCT number
- NCT03383978
- Sponsor
- Johann Wolfgang Goethe University Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-01
- Primary completion
- 2027-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.